[ Price : $8.95]
FDA sends Lundbeck Seattle Biopharmaceuticals an untitled letter alleging that promotional materials for its migraine therapy Vyep...[ Price : $8.95]
Saol Therapeutics refiles its NDA for SL1009 (sodium dichloroacetate), an investigational treatment for pyruvate dehydrogenase com...[ Price : $8.95]
FDA releases the draft MDUFA performance goals and procedures approved by CDRH and CBER for the 2027 renewal of MDUFA that will co...[ Price : $8.95]
FDA plans to publish a proposed rule by the end of the year that would require prescription drug advertisements on television, rad...[ Price : $8.95]
Three Benesh Friedlander Coplan & Aronoff attorneys say a suit against FDA filed by the Alliance for Natural Health USA could chan...[ Price : $8.95]
FDA publishes a guidance notifying blood establishments about agency recommendations for screening and deferring blood donors in r...[ Price : $8.95]
FDA warns Excelvision about CGMP violations in the production of drugs at its facility in Annonay, France.[ Price : $8.95]
FDA warns Genzyme Ireland about the failure of the firms quality control unit to ensure that drugs comply with CGMP requirements.